Entity Type
Company
- Info
- Portfolio
Filer Snapshot
Review latest filings on this page
Browse SEC filer directory
Verily Life Sciences LLC SEC EDGAR Filings
SEC filings, ownership reports, and insider transactions for CIK 0001848282.
Total Filings
29
Latest Filing
09 Apr 2026
Industry
n/a
Save or continue research
Save this filer for return loops, then jump into the latest filing evidence.
Save this research page
Create a free account to save this filer and follow future SEC filing updates.
- Business address
- 2999 Olympus Blvd, Suite 1000, Dallas, TX, 75019
- State of incorporation
- DE
- Fiscal year end
- 31 December
Quick Takeaways
- Verily Life Sciences LLC is an SEC filer tracked under CIK 0001848282.
- 29 filings are listed on this profile.
- Common form coverage includes D, 13F-NT, N-PX and more.
What Changed
- Latest filing: D filed on 09 Apr 2026.
- Report period: not specified in filing header.
Why This Matters
- You can quote filing dates and form types directly from the SEC record on this page.
- Use this profile before deeper ownership or insider analysis to confirm filing history context.
Official SEC Source
Filer Overview
Verily Life Sciences LLC has filed 29 SEC EDGAR filings since 03 Mar 2021. Common forms include D, 13F-NT, N-PX, 4 and more.
Latest Filings
Recent SEC filings for Verily Life Sciences LLC with direct links to document and filing folders.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| D | Open D document | View SEC filing for D | 09 Apr 2026 | 021-579781 | ||
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 07 Nov 2025 | 30 Sep 2025 | 028-22703 | |
| N-PX | Open N-PX document | View SEC filing for N-PX | 02 Sep 2025 | 30 Jun 2025 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 01 Aug 2025 | 30 Jun 2025 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 02 May 2025 | 31 Mar 2025 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 07 Feb 2025 | 31 Dec 2024 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 08 Nov 2024 | 30 Sep 2024 | 028-22703 | |
| N-PX | Open N-PX document | View SEC filing for N-PX | 30 Aug 2024 | 30 Jun 2024 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 02 Aug 2024 | 30 Jun 2024 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 03 May 2024 | 31 Mar 2024 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 09 Feb 2024 | 31 Dec 2023 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 13 Nov 2023 | 30 Sep 2023 | 028-22703 | |
| 4 | Open 4 document | View SEC filing for 4 | 21 Aug 2023 | 17 Aug 2023 | 001-40154 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 04 Aug 2023 | 30 Jun 2023 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 11 May 2023 | 31 Mar 2023 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 14 Feb 2023 | 31 Dec 2022 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 30 Jun 2022 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 31 Mar 2022 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 31 Dec 2021 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 30 Sep 2021 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 30 Jun 2021 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 31 Mar 2021 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 31 Dec 2020 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 30 Sep 2020 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 30 Jun 2020 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 31 Mar 2020 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 31 Dec 2019 | 028-22703 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 15 Nov 2022 | 30 Sep 2022 | 028-22703 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 03 Mar 2021 | 03 Mar 2021 | 001-40154 |
About this filer
Verily Life Sciences LLC files with the SEC under CIK 0001848282. This page aggregates EDGAR filings and related ownership activity.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.